48.12
48.12 (0%)
As of Feb 14, 2025
Guardant Health, Inc [GH]
Source:
Company Overview
Guardant Health, Inc. is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. We are transforming patient care by providing critical insights into what drives disease through our advanced blood and tissue tests and real-world data.
| Country | United States |
| Headquarters | palo alto, california |
| Phone Number | ( 855 ) 698-8887 |
| Industry | services |
| CEO | Helmy Eltoukhy |
| Website | https://guardanthealth.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $739 |
| Operating Profit | $-443.6 |
| Net Income | $-436.4 |
| Net Cash | $-503.9 |
Profit Ratios
| Gross Margin | $709.8 |
| Operating Margin | -60 |
| Profit as % of Revenues | -162.7% |
| Profit as % of Assets | -26.7% |
| Profit as % of Stockholder Equity | 312.5% |
Management Effectiveness
| Return on Equity | 312.5% |
| Return on Assets | -29.4% |
| Turnover Ratio | 45.2% |
| EBITA | $-443.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,485.6 |
| Total Liabilities | $1,625.3 |
| Operating Cash Flow | $-239.9 |
| Investing Cash Flow | $-261.3 |
| Financing Cash Flow | $-1 |
